Dominic L. Raco, MD, FRCPC
Disclosures: The commentator has disclosed no conflicts of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-2922.
Raco DL. In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding. Ann Intern Med. 2020;172:JC4. doi: https://doi.org/10.7326/ACPJ202001210-004
Download citation file:
Published: Ann Intern Med. 2020;172(2):JC4.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use